financetom
Business
financetom
/
Business
/
Warner Music Fiscal Q4 Earnings, Revenue Rise
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Warner Music Fiscal Q4 Earnings, Revenue Rise
Nov 20, 2025 5:58 AM

07:55 AM EST, 11/20/2025 (MT Newswires) -- Warner Music Group ( WMG ) reported fiscal Q4 earnings Thursday of $0.21 per diluted share, up from $0.08 a year earlier.

Analysts surveyed by FactSet expected $0.31.

Revenue for the quarter ended Sept. 30 was $1.87 billion, compared with $1.63 billion a year earlier.

Analysts polled by FactSet expected $1.68 billion.

Shares of the company were up 2.9% in recent Thursday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US House panel subpoenas tech giants over foreign communications
US House panel subpoenas tech giants over foreign communications
Feb 27, 2025
WASHINGTON, Feb 27 (Reuters) - The U.S. House Judiciary Committee has subpoenaed eight major technology companies, including Alphabet, Meta, Apple ( AAPL ) and X Corp, seeking details about their communications with other countries regarding compliance with laws impacting speech, it said on Thursday. House Judiciary Committee Chairman Jim Jordan, a Republican, sent the subpoenas on Wednesday and also included...
Kymera Therapeutics Q4 Net Loss Widens, Collaboration Revenue Falls
Kymera Therapeutics Q4 Net Loss Widens, Collaboration Revenue Falls
Feb 27, 2025
08:53 AM EST, 02/27/2025 (MT Newswires) -- Kymera Therapeutics ( KYMR ) reported a Q4 net loss Thursday of $0.88 per diluted share, wider than the loss of $0.25 a year earlier. Analysts polled by FactSet expected a loss of $0.86. Collaboration revenue for the quarter ended Dec. 31 was $7.4 million, down from $47.9 million a year earlier. Analysts...
Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise
Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise
Feb 27, 2025
09:41 AM EST, 02/27/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) shares were up 1.7% in early trading Thursday after the company reported a Q4 net loss of $0.88 per diluted share, compared with a $1.09 loss a year earlier. Analysts polled by FactSet expected a $0.94 loss. The company did not report revenue for the quarter ended Dec....
NCR Voyix Posts Q4 Adjusted Earnings Above Analysts Estimates; Revenue Falls; 2025 Guidance Set
NCR Voyix Posts Q4 Adjusted Earnings Above Analysts Estimates; Revenue Falls; 2025 Guidance Set
Feb 27, 2025
09:35 AM EST, 02/27/2025 (MT Newswires) -- NCR Voyix ( VYX ) reported Q4 non-GAAP earnings Thursday of $0.22 per diluted share. The year-earlier figure was not provided. Analysts polled by FactSet expected $0.11 per share. Revenue for the quarter ended Dec. 31 was $682 million, down from $796 million a year earlier. No comparable revenue estimates were available. NCR...
Copyright 2023-2026 - www.financetom.com All Rights Reserved